Delivery Order 75N93021D00004-75N93023F00002
Award Date 8/16/23
Potential Completion Date 8/15/25
Potential Value $228K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the prime contractor Research Triangle Institute (RTI International). The $334,662.00 cost-plus-fixed-fee contract is for conducting confirmatory and specialized in vitro testing and screening of interventional agents. The contract is not set aside for any specific business category. RTI International, a prominent non-profit research organization, will serve as the prime...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded Research Triangle Institute (RTI International) a $1.48 million delivery order on August 1, 2024, for HIV assay development and testing to identify targeted activator of cell kill molecules. The contract is structured as a cost-plus-fixed-fee arrangement with performance scheduled through September 14, 2026, and will be executed at RTI's Research Triangle Park, North Carolina facility. This delivery order is issued under...
- This task order funds the guaranteed minimum amount under the prime contract between Research Triangle Institute (RTI) International and the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose is to support preclinical services for HIV therapeutics research under the larger Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. With a potential value of $0.00, this delivery order was awarded on October 15, 2020 to RTI...
- This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
- This is a $403,478.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for conducting hit-to-lead progression studies on investigational agents for the treatment of HIV. This work will be performed under NIAID's Preclinical Services for HIV Therapeutics indefinite...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...
- This task order was awarded to Research Triangle Institute, doing business as RTI International, as the prime contractor. RTI will develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting in support of the Preclinical Services for HIV Therapeutics program, a $17,299 cost-plus-fixed-fee delivery order issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The work is being performed under the...
- This is a Cost Plus Fixed Fee federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $249,997 contract is for the identification of anti-HIV lead compounds as part of NIAID's in vitro testing resource for HIV therapeutics and topical microbicides. Southern Research Institute, which holds multiple federal indefinite...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $254,076.51 cost-plus-fixed-fee delivery order contract was awarded to Southern Research Institute, a non-profit organization that provides advanced drug discovery and development services. The contract supports high-throughput screening to identify HIV inhibitors as part of NIAID's "In Vitro Testing...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
- Preclinical Services for HIV TherapeuticsMaster IDIQ
- 75N93021D00004Indefinite Delivery Contract
- 75N93021D00004-75N93023F00002Delivery Order
This is a $227,601 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Preclinical Services for HIV Therapeutics Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The purpose is to conduct in vitro screening of interventional agents in high throughput screening (HTS) formats to identify HIV inhibitors. The prime contractor is Research Triangle Institute (RTI International), a non-profit research organization. Two subcontractors are involved: Chemdiv, Inc., a for-profit company providing compound libraries, and Imquest Biosciences, Inc., a for-profit preclinical contract research organization. This award is not set aside for any specific business types.
Generated 8/10/24, 9:26 AM
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
POC000631770S | Chemdiv, Inc. | Delivery Order 75N93021D00004-75N93023F00002 | $35.0k | 2/6/24 | |
13400217788TASKORDER2S | Imquest Biosciences, Inc. | Delivery Order 75N93021D00004-75N93023F00002 | $25.0k | 12/4/23 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 8/8/24 | |
| Not listed | Not listed | $227.6k | 8/16/23 |